Recruiting

Ultrasound System vs. Imaging Modalities

Sponsor:

MAUI Imaging, Inc.

Code:

NCT05748106

Conditions

Image-Guided Biopsies and/or Ablations

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Ultrasound-based imaging

Study Details

Brief summary:

This is an observational study comparing a novel ultrasound-based imaging system (MAUI K3900) to standard-of-care (SoC) imaging systems used to guide and/or manage interventional radiologic procedures such as solid organ biopsies or lesion ablations.

Conditions

Image-Guided Biopsies and/or Ablations

Study ID

NCT05748106

Start date

Feb 15, 2023

Status verified date

Feb, 2023

Completion date

Jun 30, 2023

Anticipated

Primary completion date

May 30, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Undergoing standard / routine interventional radiologic procedure

Exclusion Criteria:

  • Unwilling or unable to provide informed consent

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Interventions

Ultrasound-based imaging

Ultrasound-based imaging

Primary outcome measure

  • Usefulness relative to standard imaging for image-guided solid organ biopsies and/or ablations [ Time Frame: Up to 26 weeks ]

Central Contacts and Locations

Central contacts

John C Cheronis, MD/PhD

3034354074john.cheronis@mauiimaging.com

Locations

Texas Health Presbyterian Hospital

Recruiting

Dallas, Texas, United States, 75231

Contacts

Noah B Appel, MD

214-345-7700NoahAppel@texashealth.org

Principal Investigator:

Noah B Appel, MD

More Information

Sponsor

MAUI Imaging, Inc.

Last update posted

Mar 1, 2023

Last verified

Feb, 2023

Keywords

  • Ultrasound Imaging
  • Interventional Radiology
  • Image-guided biopsy
  • Image-guided tumor ablation
  • Image-guided procedures

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by MAUI Imaging, Inc. on 2023-03-01.